Secondary glioblastoma multiforme after treatment for primary choroid plexus carcinoma in childhood

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 4, 2007, Pages 248-252

  Postovsky, Sergey ^a   Vlodavsky, Eugene ^b   Eran, Ayelet ^b   Guilburd, Joseph ^b   Ben Arush, Myriam Weyl ^a  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Choroid plexus carcinoma; Glioblastoma multiforme; Second cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; VINCRISTINE;

ADOLESCENT; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; CHOROID PLEXUS TUMOR; DISEASE ASSOCIATION; FOLLOW UP; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; LABORATORY TEST; LATERAL BRAIN VENTRICLE; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHOROID PLEXUS NEOPLASMS; CISPLATIN; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; ETOPOSIDE; FATAL OUTCOME; GLIOBLASTOMA; HUMANS; MALE; NEOPLASMS, SECOND PRIMARY; VINCRISTINE;

EID: 34247157294     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31804a570b     Document Type: Article

References (20)

1. McEvoy AW, Harding BN, Phipps KP, et al. Management of choroid plexus tumors in children: 20 years experience at a single neurosurgical center. Pediatr Neurosurg. 2000;32:192-199.
2. Pierga JY, Kalifa C, Terrier-Lacombe MJ, et al. Carcinoma of the choroid plexus: a pediatric experience. Med Pediatr Oncol. 1993;21:480-487.
3. Berger C, Thiesse P, Lellouch-Tubiana A, et al. Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurgery. 1998;42:470-475.
4. Dickens DS, Dothage JA, Heideman RL, et al. Successful treatment of an unresectable choroid plexus carcinoma in a patient with Li-Fraumeni syndrome. J Pediatr Hematol Oncol. 2005;27:46-49.
5. Vital A, Bringuier PP, Huang H, et al. Astrocytomas and choroid plexus tumors in two families with identical p53 germline mutations. J Neuropathol Exp Neurol. 1998;57:1061-1069.
6. Lubbe J, von Ammon K, Watanabe K, et al. Familial brain tumour syndrome associated with a p53 germline deletion of codon 236. Brain Pathol. 1995;5:15-23.
7. Garber JE, Burke EM, Lavally BL, et al. Choroid plexus tumors in the breast cancer-sarcoma syndrome. Cancer. 1990;66:2658-2660.
8. Mike V, Meadows AT, D'Angio GJ. Incidence of second malignant neoplasms in children: results of an international study. Lancet. 1982;2:1326-1331.
9. Duffner PK, Krisher JP, Horowitz ME, et al. Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group Study. Ann Neurol. 1998;44:300-302.
10. Hall AG, Tilby MJ. Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of hematological malignancies. Blood Rev. 1992;6:163-173.
11. Pommier Y. DNA topoisomerases I and II in cancer chemotherapy: update and perspectives. Cancer Chemother Pharmacol. 1993;32:103-108.
12. Gold DG, Neglia JP, Dusenbery KE. Second neoplasms after megavoltage radiation for pediatric tumors. Cancer. 2003;97:2588-2596.
13. Hisada M, Garber JE, Fung CY, et al. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst. 1998;90:606-611.
14. Heyn R, Haeberlen V, Newton WA, et al. Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol. 1993;11:262-270.
15. Prime SS, Thakker NS, Pring M, et al. A review of inherited cancer syndromes and their relevance to oral squamous cell carcinoma. Oral Oncol. 2001;37:216-217.
16. Hansen MF, Koufos A, Gallie BL, et al. Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA. 1985;82:6216-6220.
17. Broniscer A, Ke W, Fuller CE, et al. Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude Children's Research Hospital experience. Cancer. 2004;100:2246-2252.
18. Malkin D, Jolly KW, Barbier N, et al. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med. 1992;326:1309-1315.
19. Bhattacharjee MB, Bruner JM. P53 in pediatric malignant astrocytomas: a study of 21 patients. J Neurooncol. 1997;32:225-233.
20. Litofsky NS, Hinton D, Raffel C. The lack of a role for p53 in astrocytomas in pediatric patients. Neurosurgery. 1994;34:976-972.